Phase I study of continuous oral administration of lonafarnib (Sarasar (TM)) in patients with advanced hematologic malignancies

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): List AF, DeAngelo D, O'Brien S, Cortes J, Wilson J, Sugrue MM, Zhu YL, Statkevich P, Baum C, Zaknoen S

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 44th Annual Meeting of the American Society of Hematology

Year of Conference: 2002

Pages: 789A-789A

Publisher: Blood: American Society of Hematology

Notes: Abstract 3120

Library holdings: Search Newcastle University Library for this item

ISBN:

ePrints